Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,28116,300 of 20,252 grants

Active TRAINING, INDIVIDUAL
The Role of Glutamine Metabolism in Monocyte-Derived Dendritic Cell Differentiation in the Soft-Tissue Sarcoma Microenvironment
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2026

PROJECT SUMMARY Soft-tissue sarcomas (STS) are a diverse and often fatal set of malignancies arising from connective tissue with a 16% five-year survival rate for metastatic diseas...

$351.3K
USD
Active NON-SBIR/STTR RPGS
Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2026

PROJECT SUMMARY AND ABSTRACT Metastatic castration-resistant prostate cancer (mCRPC) is the most lethal state of prostate cancer (PCa) and remains as the most challenging issue in...

$6.26M
USD
Completed NON-SBIR/STTR RPGS
Reviving cancer immune surveillance with CD4 T cell help
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2025

Abstract The immune system is capable of eliminating advanced malignant tumors, yet cancer immunotherapy success has been limited to a subset of cancer types. Conventional CD4, or...

$2.46M
USD
Active NON-SBIR/STTR RPGS
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

Project Summary/Abstract CD19-targeted chimeric antigen receptor (CAR) T cell therapy has shown remarkable treatment effects in B-cell malignancies, but many patients suffer from l...

$5.23M
USD
Active NON-SBIR/STTR RPGS
Therapeutic resistance and aggressive malignancy in glioblastomas: the contribution of GTP metabolism through regulation by IMPDH2
NATIONAL CANCER INSTITUTE University of Cincinnati United States 2021 – 2026

Summary Glioblastoma multiforme (GBM) is the most aggressive and lethal of all brain tumors.Despite extensive efforts to improve treatment, current GBM therapy only marginally prol...

$4.13M
USD
Completed NON-SBIR/STTR RPGS
Cross Sectional Association of the Oral Microbiota and the Inflammasome with Oral HPV among HIV+ Adults
NATIONAL CANCER INSTITUTE Comprehensive Cancer Center/ Univ/Pr United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT HPV-infection is the most common sexually transmitted disease (STI), and it accounts for 70% of oropharyngeal cancers.People living with HIV (PLWH) are dis...

$1.74M
USD
Completed NON-SBIR/STTR RPGS
Cross Sectional Association of the Oral Microbiota and the Inflammasome with Oral HPV among HIV+ Adults
NATIONAL CANCER INSTITUTE Comprehensive Cancer Center/ Univ/Pr United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT HPV-infection is the most common sexually transmitted disease (STI), and it accounts for 70% of oropharyngeal cancers. People living with HIV (PLWH) are di...

$1.5M
USD
Active NON-SBIR/STTR RPGS
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

Project Summary/Abstract CD19-targeted chimeric antigen receptor (CAR) T cell therapy has shown remarkable treatment effects in B-cell malignancies, but many patients suffer from l...

$5.52M
USD
Active NON-SBIR/STTR RPGS
Therapeutic resistance and aggressive malignancy in glioblastomas: the contribution of GTP metabolism through regulation by IMPDH2
NATIONAL CANCER INSTITUTE University of Cincinnati United States 2021 – 2026

Summary Glioblastoma multiforme (GBM) is the most aggressive and lethal of all brain tumors. Despite extensive efforts to improve treatment, current GBM therapy only marginally pro...

$4.04M
USD
Completed NON-SBIR/STTR RPGS
Cross Sectional Association of the Oral Microbiota and the Inflammasome with Oral HPV among HIV+ Adults
NATIONAL CANCER INSTITUTE Comprehensive Cancer Center/ Univ/Pr United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT HPV-infection is the most common sexually transmitted disease (STI), and it accounts for 70% of oropharyngeal cancers. People living with HIV (PLWH) are di...

$573K
USD
Active NON-SBIR/STTR RPGS
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

Project Summary/Abstract CD19-targeted chimeric antigen receptor (CAR) T cell therapy has shown remarkable treatment effects in B-cell malignancies, but many patients suffer from l...

$6.69M
USD
Active NON-SBIR/STTR RPGS
Therapeutic resistance and aggressive malignancy in glioblastomas: the contribution of GTP metabolism through regulation by IMPDH2
NATIONAL CANCER INSTITUTE University of Cincinnati United States 2021 – 2026

Summary Glioblastoma multiforme (GBM) is the most aggressive and lethal of all brain tumors. Despite extensive efforts to improve treatment, current GBM therapy only marginally pro...

$3.88M
USD
Active NON-SBIR/STTR RPGS
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

Project Summary/Abstract CD19-targeted chimeric antigen receptor (CAR) T cell therapy has shown remarkable treatment effects in B-cell malignancies, but many patients suffer from l...

$5.62M
USD
Active NON-SBIR/STTR RPGS
Therapeutic resistance and aggressive malignancy in glioblastomas: the contribution of GTP metabolism through regulation by IMPDH2
NATIONAL CANCER INSTITUTE University of Cincinnati United States 2021 – 2026

Summary Glioblastoma multiforme (GBM) is the most aggressive and lethal of all brain tumors. Despite extensive efforts to improve treatment, current GBM therapy only marginally pro...

$3.67M
USD
Active NON-SBIR/STTR RPGS
Novel noncanonical actions of CAR in human Liver
NATIONAL CANCER INSTITUTE University of Maryland Baltimore United States 2021 – 2026

Project Summary The constitutive androstane receptor (CAR; NR1i3) is a well-established xenobiotic sensor that regulates the expression of numerous genes encoding proteins importan...

$3.91M
USD
Active NON-SBIR/STTR RPGS
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

PROJECT SUMMARY Androgens are well known to be immunosuppressive, yet cancer immunotherapy is used without consideration of local androgen concentrations or the sex of the patient....

$5.48M
USD
Active NON-SBIR/STTR RPGS
Inside-Out Nonlinear Gradients to Improve Diffusion MRI
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2026

Project Summary/Abstract The lifetime risk of prostate cancer is 1 in 9 and it remains the 2nd leading cancer killer of men.Yet many patients with low grade disease receive prematu...

$3.83M
USD
Active NON-SBIR/STTR RPGS
Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and Communities
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2027

PROJECT SUMMARY Among the devastating illnesses impacting rural America, few exact the physical, social, psychological, and economic toll of lung cancer. Lung cancer is the leading...

$5.93M
USD
Active NON-SBIR/STTR RPGS
Inside-Out Nonlinear Gradients to Improve Diffusion MRI
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2026

Project Summary/Abstract The lifetime risk of prostate cancer is 1 in 9 and it remains the 2nd leading cancer killer of men. Yet many patients with low grade disease receive premat...

$3.75M
USD
Active NON-SBIR/STTR RPGS
Novel noncanonical actions of CAR in human Liver
NATIONAL CANCER INSTITUTE University of Maryland Baltimore United States 2021 – 2026

Project Summary The constitutive androstane receptor (CAR; NR1i3) is a well-established xenobiotic sensor that regulates the expression of numerous genes encoding proteins importan...

$3.91M
USD